Talk to your doctor before taking potassium supplements, potassium-sparing diuretics, or salt substitutes along with Refsav 50 Tablet as it might cause an increase in serum potassium and serum creatinine levels.

Refsav 50 Tablet may cause a headache as a common side effect, especially in the first few days of treatment. However, if the condition persists or worsens, please consult a doctor to reduce the dose initially.

Refsav 50 Tablet is not recommended for patients with severe hypotension (low blood pressure) as it may increase the risk of worsening the condition. Therefore, inform your doctor if you have low blood pressure before taking Refsav 50 Tablet .

Avoid taking Refsav 50 Tablet with ramipril as it might cause angioedema (swelling of the face, throat, hands, and legs). Refsav 50 Tablet should not be administered within 36 hours of switching from or to an ACE inhibitor such as ramipril.

Refsav 50 Tablet may cause dizziness due to low blood pressure. If you experience dizziness after taking Refsav 50 Tablet , do not try to stand up suddenly or start walking, instead lie down and get up slowly only when you feel better.

Refsav 50 Tablet may cause muscle weakness due to high potassium levels. Consult the doctor if you experience muscle weakness, weak pulse, tingly feeling or slow heart rate as these could be signs of high potassium.

Refsav 50 Tablet is not a diuretic medicine. It contains Valsartan and Sacubitril which belong to the class of drugs called angiotensin receptor neprilysin inhibitors (ARNI).

Refsav 50 Tablet should be avoided in patients who are allergic to any of its components or have a history of angioedema with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARB) therapy. It is also contraindicated with concomitant use of angiotensin-converting enzyme (ACE) inhibitors and aliskiren in patients with diabetes.

Inform your doctor before taking Refsav 50 Tablet if you have kidney or liver problems, if you are pregnant or breastfeeding, or if you have a history of hereditary angioedema (rapid oedema or swelling beneath the area of skin).

Refsav 50 Tablet should not be used during pregnancy as it may cause foetal harm. When pregnancy is detected, Refsav 50 Tablet should be discontinued as soon as possible and alternate treatment should be considered.

Signs of high potassium include muscle weakness, weak pulse, tingly feeling or slow heart rate.

Refsav 50 Tablet can be taken with or without food.

If you miss a dose of Refsav 50 Tablet , take it as soon as you remember. If it is close to your next dose, do not take the missed dose. Take the next dose at your regular time.

Refsav 50 Tablet is not recommended in people with severe liver impairment. Consult the doctor if you have kidney or liver disease. Dose adjustment may be needed in patients with kidney or liver problems.

Refsav 50 Tablet may cause side effects such as cough, dizziness, nausea, diarrhoea, and weakness. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.